60 Degrees Pharmaceuticals, Inc.

60 Degrees Pharmaceuticals, Inc. (SXTP) priced its initial public offering on Jul 13, 2023 at $5.30 per share, raising $7.5M, and listed on Nasdaq Capital Market. At the IPO price its market capitalization was about $29.5M. Carmel, Milazzo & Feil advised the company.

60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company developing and commercializing therapies to prevent and treat infectious diseases. It has approval for Arakoda, a malaria preventative on the market since late 2019, and has programs for COVID-19, fungal, tick-borne and other viral diseases.

Status

IPO

Ticker

SXTP

Exchange

Nasdaq Capital Market

Priced

Jul 13, 2023

IPO price

$5.30

Raised

$7.5M

Market cap at IPO price

$29.5M

First filed

Jan 31, 2023

Company counsel

Carmel, Milazzo & Feil

Sector

Biotech & pharma

Country / state

DC

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.